InvestorsHub Logo
Followers 5
Posts 71
Boards Moderated 0
Alias Born 12/15/2011

Re: Gnyce3 post# 75159

Friday, 10/17/2014 3:07:00 PM

Friday, October 17, 2014 3:07:00 PM

Post# of 92948
I agree, I have owned this stock for several years because of the promising initial study results. I am a physician and the Lancet results and the study results today on the platelets is truly game changing. I know the eye studies will take a couple years unless they got early approval from the FDA for compassionate care treatment. The platelet studies will now need to be tested in humans. The good thing is once these studies start it will not take long to see results. They could easily recruit hundreds to thousands of patients in a controlled study in a very short period of time and they will have initial results within days based on the life of platelets as to whether they are as effective in humans as natural platelets are. I have not sold any of my stock but I am still totally confused as to why there was not a major move up. I understand the dilution but when you talk about a market of multi billions of dollars the dilution is nothing.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.